Atherosclerosis and Hyperlipidemia

Articles

Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker

Citation:

European Cardiology Review 2017;12(2):96.

Cardiovascular Risk Management Targeting Inflammation in Addition to Lipid-lowering Therapy

Citation:

European Cardiology Review 2017;12(2):88

Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease

Citation:

US Cardiology Review 2017;11(1):16–7

Featuring: Dr Valentin Fuster

Citation:

European Cardiology Review 2016;11(2):123-5